Source: Revenio Group Oyj
Revenio Group Oyj Stock Exchange Release January 30, 2014 at 14:00 p.m.
INVITATION TO REVENIO'S RESULTS BRIEFING
Revenio will publish its Financial Statement regarding 2013 on Wednesday, 12
February at 9.00 a.m.
A briefing for financial analysts, investors and representatives of the media
will be held on Wednesday, 12 Ferbruary at 12:00 p.m. at Ravintola Palace,
Eteläranta 10, 10(th) floor, 00130 Helsinki. The briefing will be held in
President and CEO Olli-Pekka Salovaara and CFO Pekka Raatikainen will present
the Financial Statement regarding 2013.
A light buffet lunch will be served at the briefing. Please inform Elina Kari of
your participation and possible special diet in advance, but no later than
6.2.2014 at firstname.lastname@example.org. Please note that the number of attendants is
The statement will be available on Revenio's website www.revenio.fi after the
Revenio Group Oyj
President & CEO
For additional information:
Pekka Raatikainen, CFO
Tel. +358 50 553 4094
NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
The Revenio Group in brief
Revenio is a Finnish health tech group whose core business is tonometers. The
Revenio Health Tech segment comprises the business operations of Icare Finland
Oy. The widely patented Icare product family is the current cornerstone of the
Group's success. Revenio seeks vigorous growth in health technology, both
organically and through acquisitions and mergers.
The Revenio Group also includes other business operations, which are grouped
under the Technology and Services segment. This segment's operations have a
shared global market and represent the cutting edge of technology products and
services in their industry. These businesses are extremely profitable in their
industries and generate positive cash flow.
In 2012, the Revenio Group's net sales totaled EUR 25.4 million, with its
operating margin standing at 19.4%. The Revenio Group Corporation is listed on
NASDAQ OMX Helsinki.